The suppression of prion propagation using poly-l-lysine by targeting plasminogen that stimulates prion protein conversion
✍ Scribed by Chongsuk Ryou; William B. Titlow; Charles E. Mays; Younsoo Bae; Sehun Kim
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 979 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0142-9612
No coin nor oath required. For personal study only.
✦ Synopsis
Poly-L-lysine (PLL), a homopolymer of amino acid L-lysine (LL), has been frequently used for drug delivery. Here, we report that PLL is an effective agent to inhibit propagation of prions that cause fatal and incurable neurologic disorders in humans and animals, termed prion diseases. In our recent investigation on prion propagation facilitated by conversion of the cellular prion protein (PrP) to the misfolded, disease-associated PrP (PrP Sc ), we demonstrated that plasminogen stimulates PrP conversion as a cellular cofactor. In the current study, we targeted plasminogen using PLL and assessed its anti-prion efficacy. The results showed that PLL strongly inhibited PrP Sc propagation in the cell-free, cell culture, and mouse models of prion disease. These results confirm the role of plasminogen in PrP Sc propagation, validates plasminogen as a therapeutic target to combat prion disease, and suggests PLL as a potential anti-prion agent. Therefore, our study represents a proof-of-concept that targeting plasminogen, a cofactor for PrP conversion, using PLL results in suppression of prion propagation, which represents a successful translation of our understanding on details of prion propagation into a potential therapeutic strategy for prion diseases.